Navigation Links
BioPharmX Violet Iodine Mobile Marketing Campaign On Pandora Achieves 25 Times the Average Industry Response
Date:1/12/2016

MENLO PARK, Calif., Jan. 12, 2016 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX) today announced that its preliminary campaign test results of advertising on Pandora (NYSE: P), the world's most powerful music discovery platform, show that personalized, streaming radio is an innovative, effective way to drive consumer awareness of Violet® iodine, a new breast health supplement for women.

The month-long test in New York, Los Angeles and Houston found that consumers responded to the Violet® ads on Pandora at more than 25 times the average rate for pharmaceutical digital display ads in the United States. In addition, the response rates outpaced even Pandora pharmaceutical benchmarks – which are typically higher than other channels – by 20 percent.

The program drove a nearly 300 percent increase in unique visits to the Violet brand website from the test markets during the campaign. There were also incremental increases in sales in those markets.

"As a company built on innovative research and product development to fulfill unmet medical needs, our cultural DNA is grounded on improving consumers' lives," said Anja Krammer, president and cofounder of BioPharmX.  "We use novel approaches to engage our customers, educate them about our products and encourage them to experience the benefits they offer. Pandora offers us unique and effective ways to reach our target audience when they are mobile."

The BioPharmX test targeted health-oriented women who are 30 to 44 years old.   Pandora's mobile audio programming delivered the Violet iodine ad to these listeners in a clutter-free environment, ensuring that the message did not have to compete for attention.

As a result of the initial program success, BioPharmX has expanded its Pandora advertising program to five additional U.S. markets this year.

"BioPharmX understands how consumer trends and behaviors are changing.  Pandora listeners, who once relied on traditional broadcast radio, now spend 80 percent of their total listening hours on mobile and other connected devices. BioPharmX is making innovative use of Pandora to precisely reach active consumers," said Andy Lipset, vice president of broadcast and local at Pandora. "We are thrilled that Pandora has helped BioPharmX reach audiences most likely to benefit from Violet iodine."

Pandora is the leading music streaming service, with more than 78 million active monthly listeners in the United States.  The average Pandora listener tunes in for over 21 hours every month.

About BioPharmX® Corporation

BioPharmX Corporation (NYSE MKT: BPMX) is a Silicon Valley-based specialty pharmaceutical company, which seeks to provide products through proprietary platform technologies for prescription, over-the-counter (OTC), and supplement applications in the health and wellness markets, including dermatology and women's health. To learn more about BioPharmX, visit www.BioPharmX.com.

BioPharmX and Violet are registered trademarks of BioPharmX, Inc. All other brand and product names are trademarks or registered trademarks of their respective holders.

Logo - http://photos.prnewswire.com/prnh/20150711/235327LOGO

 


'/>"/>
SOURCE BioPharmX Corporation
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. MarketPublishers.com Added New Report on Povidone Iodine (CAS 25655-41-8) Market to Its Catalogue
2. Pivotal Phase 3 Trial of Investigational Agent Lenvatinib in Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer Published in New England Journal of Medicine
3. Lucintel's Analysis of Global Catalysts Industry: Chemical and Automobile Industries Play Crucial Role in Growth
4. Self-assembled nanostructures enable a low-power phase-change memory for mobile electronic devices
5. SoundMindz TM Releases ‘Anti-Anxiety TM’ Mobile App - A Complete Stress Therapy Program
6. MedForward Launches Newly Redesigned MedForward.com, Now Offering Mobile Site Design Services to Increase Website Accessibility for Smartphones and Tablets
7. J. Craig Venter Institutes Mobile Genomics Lab Launches First School Visits in San Diego County
8. ReachMD Adds ‘Oncology Power Hour’ to Weekly Line Up, Delivering Expert Opinions and Medical Interviews to On Air, Online, and Mobile Learners
9. Celebrate Dads and Grads This Year with Mobile Accessories from iLuv
10. Pursuit's Elissa Guerra and Eunjoo Pluenneke to Present on Mobile Strategy at Digital Pharma West Conference
11. Study Scavenger and CenterWatch Partner to Improve Patient Recruitment, Enrollment and Mobile Access to Clinical Trials with New Study Scavenger Smartphone App
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):